AbbVie introduces Produodopa for advanced Parkinson's in EU
AbbVie has announced the launch of Produodopa, a new treatment for advanced Parkinson's disease (PD) patients in the European Union.
Decentralized Procedure News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Decentralized Procedure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Decentralized Procedure Today - Breaking & Trending Today
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
- PRODUODOPA® is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson's disease - PRODUODOPA demonstrated sustained...
Source: marketscreener.com
Moberg Pharma´s Interim report January - June 2023
Moberg Pharma´s Interim report January - June 2023MOB-015 IS RECOMMENDED FOR APPROVAL IN 13 EUROPEAN COUNTRIES SIX-MONTH PERIOD (JAN-JUN 2023)· EBITDA SEK -10.7 million (-9.1)· Operating profit (EBIT) SEK -12.0 million (-10.4)&middo...
Source: pharmiweb.com
MOB-015 is recommended for approval in EU: Moberg Pharma
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended...
Source: prnewswire.com
Ipsen : delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance
Paris , 22 April 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the first quarter of 2021: Q1 2021 sales summary ... | June 16, 2023
Source: marketscreener.com